I3786

Sigma-Aldrich

Protease Inhibitor Cocktail, Animal Component Free

for use with mammalian cell and tissue extract, DMSO solution

NACRES:
NA.77
Pricing and availability is not currently available.

Quality Level

form

DMSO solution

storage temp.

−20°C

Looking for similar products? Visit Product Comparison Guide

General description

This protease inhibitor cocktail has been optimized and tested for mammalian cell and tissue extracts.
Components of this cocktail are of non-animal origin and no animal products were used in the component production process. All vessels and instruments used for the cocktail production are dedicated for animal component free production and have never encountered an animal product. Aprotinin used in this cocktail is a recombinant bovine protein expressed in plants (Nicotiana).

Specificity

Inhibits serine, cysteine, aspartic proteases, and aminopeptidases.

Application

Animal component free (ACF). Optimized and tested for general use. Can also be used for purification of histidine-tagged proteins, as chelating agents have been omitted.

Components

AEBSF
Aprotinin
Bestatin
E-64
Leupeptin
Pepstatin A

Physical form

This ACF cocktail is supplied as a ready-to-use solution in DMSO. One ml of the cocktail solution is recommended for the inhibition of endogenous enzymes found in 100 mL of lysate from 20 g (wet weight) of bovine liver, or 10 mL of cell lysate obtained from CHO cells at a cell density of 108 cells per mL.
The components in this ACF protease inhibitor cocktail do not originate from animal sources and can thus be used in the production of animal-free proteins.

RIDADR

NA 1993 / PGIII

WGK Germany

WGK 2

Flash Point(F)

188.6 °F - closed cup

Flash Point(C)

87 °C - closed cup

Certificate of Analysis
Certificate of Origin
Mo Shen et al.
Molecular medicine reports, 16(1), 937-942 (2017-06-07)
The role of inflammation in tumorigenesis and development is currently well established. Lymphotoxin β receptor (LTβR) activation induces canonical and noncanonical nuclear factor (NF)‑κB signaling pathways, which are linked to inflammation‑induced carcinogenesis. In the present study, 5,637 bladder cancer cells were...
Wimonrat Panpetch et al.
Frontiers in immunology, 11, 561652-561652 (2020-10-27)
Obesity induces gut leakage and elevates serum lipopolysaccharide (LPS), a major cell wall component of Gram-negative bacteria, through gut translocation. Because Candida albicans is prominent in human gut but not in mouse, C. albicans, a source of (1→3)-β-D-glucan (BG) in...
Paulo Emílio Corrêa Leite et al.
Toxicology in vitro : an international journal published in association with BIBRA, 29(5), 819-827 (2015-03-21)
Gold nanoparticles (AuNP) have been widely used for many applications, including as biological carriers. A better understanding concerning AuNP safety on muscle cells is crucial, since it could be a potential tool in the nanomedicine field. Here, we describe the...
Diogo B Peruchetti et al.
Frontiers in physiology, 11, 172-172 (2020-03-17)
Increasing evidence has highlighted the role of tubule-interstitial injury (TII) as a vital step in the pathogenesis of acute kidney injury (AKI). Incomplete repair of TII during AKI could lead to the development of chronic kidney disease. Changes in albumin...
Diogo B Peruchetti et al.
Archives of biochemistry and biophysics, 674, 108115-108115 (2019-09-29)
Evidence points to a possible role of tubular sodium reabsorption in worsening renal injury. Proximal tubule (PT) albumin overload is a critical process in the development of tubule-interstitial injury (TII), and consequently in progression of renal disease. We studied the...

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service

Social Media

LinkedIn icon
Twitter icon
Facebook Icon
Instagram Icon

MilliporeSigma

Research. Development. Production.

We are a leading supplier to the global Life Science industry with solutions and services for research, biotechnology development and production, and pharmaceutical drug therapy development and production.

© 2021 Merck KGaA, Darmstadt, Germany and/or its affiliates. All Rights Reserved.

Reproduction of any materials from the site is strictly forbidden without permission.